AAAAAA

   
Results: 1-16 |
Results: 16

Authors: BUCHHOLZ RA
Citation: Ra. Buchholz, THE ETHICS OF CONSUMPTION ACTIVITIES - A FUTURE PARADIGM, Journal of business ethics, 17(8), 1998, pp. 871-882

Authors: ROSENTHAL S BUCHHOLZ RA
Citation: S. Rosenthal et Ra. Buchholz, BRIDGING ENVIRONMENTAL AND BUSINESS ETHICS - A PRAGMATIC FRAMEWORK, Environmental ethics, 20(4), 1998, pp. 393-408

Authors: ARSTALL MA ZHAO YZ HORNBERGER L KENNEDY SP BUCHHOLZ RA OSATHANONDH R KELLY RA
Citation: Ma. Arstall et al., HUMAN VENTRICULAR MYOCYTES IN-VITRO EXHIBIT BOTH EARLY AND DELAYED PRECONDITIONING RESPONSES TO SIMULATED ISCHEMIA, Journal of Molecular and Cellular Cardiology, 30(5), 1998, pp. 1019-1025

Authors: HILL RJ OLEYNEK JJ HOTH CF KIRON MAR WENG WF WESTER RT TRACEY WR KNIGHT DR BUCHHOLZ RA KENNEDY SP
Citation: Rj. Hill et al., CLONING, EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF RABBIT ADENOSINE A(1) AND A(3) RECEPTORS, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 122-128

Authors: TRACEY WR MAGEE W MASAMUNE H KENNEDY SP KNIGHT DR BUCHHOLZ RA HILL RJ
Citation: Wr. Tracey et al., SELECTIVE ADENOSINE A(3) RECEPTOR STIMULATION REDUCES ISCHEMIC MYOCARDIAL INJURY IN THE RABBIT HEART, Cardiovascular Research, 33(2), 1997, pp. 410-415

Authors: DEGARAVILLA L PAGANI ED BUCHHOLZ RA DUNDORE R BODE DC VOLBERG ML JACKSON KN PRATT P SILVER PJ
Citation: L. Degaravilla et al., ZAPRINAST, BUT NOT DIPYRIDAMOLE, REVERSES HEMODYNAMIC TOLERANCE TO NITROGLYCERIN IN-VIVO, European journal of pharmacology, 313(1-2), 1996, pp. 89-96

Authors: HILL RJ OLEYNEK JJ KIRON MAR MASAMUNE H WENG WF BUCHHOLZ RA KNIGHT DR TRACEY WR WESTER RT KENNEDY SP
Citation: Rj. Hill et al., CHARACTERIZATION OF IBMECA AS A POTENT AND SELECTIVE AGONIST OF CLONED HUMAN AND RABBIT ADENOSINE A3 RECEPTORS, Circulation, 94(8), 1996, pp. 3217-3217

Authors: SMITH AH BANGERTER FW MACANDREW JT TRACEY WR HILL RJ KENNEDY SP MASAMUNE H WIESLER RT BUCHHOLZ RA
Citation: Ah. Smith et al., IBMECA, A SELECTIVE RABBIT ADENOSINE A3 RECEPTOR AGONIST, PHARMACOLOGICALLY PRECONDITIONS WITHOUT HEMODYNAMIC-EFFECTS, IN-SITU, Circulation, 94(8), 1996, pp. 3218-3218

Authors: DUNDORE RL PAGANI ED BODE DC BACON ER SINGH B LESHER GY BUCHHOLZ RA SILVER PJ
Citation: Rl. Dundore et al., SPECIES-DEPENDENT PHARMACODYNAMIC EFFECTS OF THE SELECTIVE LOW K-M CYCLIC-AMP PHOSPHODIESTERASE-III INHIBITORS WIN-58993 AND WIN-62005, Journal of cardiovascular pharmacology, 25(1), 1995, pp. 14-21

Authors: DEPASQUALE MJ RINGER LW WINSLOW RL BUCHHOLZ RA FOSSA AA
Citation: Mj. Depasquale et al., CHRONIC MONITORING OF CARDIOVASCULAR FUNCTION IN THE CONSCIOUS GUINEA-PIG USING RADIOTELEMETRY, Clinical and experimental hypertension, 16(2), 1994, pp. 245-260

Authors: FOSSA AA BUCHHOLZ RA
Citation: Aa. Fossa et Ra. Buchholz, INTERRELATIONSHIP OF GENERAL PHARMACOLOGY STUDIES WITH DRUG DISCOVERYAND DEVELOPMENT, CLINICAL MEDICINE, AND REGULATORY AFFAIRS, Drug development research, 32(4), 1994, pp. 217-222

Authors: MANGIAPANE ML RAUCH AL MACANDREW JT ELLERY SS HOOVER KW KNIGHT DR JOHNSON HA MAGEE WP CUSHING DJ BUCHHOLZ RA
Citation: Ml. Mangiapane et al., VASOCONSTRICTOR ACTION OF ANGIOTENSIN-I CONVERTASE AND THE SYNTHETIC SUBSTRATE (PRO(11),D-ALA(12))-ANGIOTENSIN-I, Hypertension, 23(6), 1994, pp. 857-860

Authors: PAGANI ED DUNDORE RL BODE DC BACON ER SINGH B LESHER GY BUCHHOLZ RA SILVER PJ
Citation: Ed. Pagani et al., PHARMACOLOGICAL AND PHARMACODYNAMIC EFFECTS OF THE SELECTIVE LOW K-M CYCLIC-AMP PHOSPHODIESTERASE-III INHIBITORS WIN-63291 AND WIN-62582, Journal of cardiovascular pharmacology, 24(3), 1994, pp. 403-410

Authors: SILVER PJ DUNDORE RL BODE DC DEGARAVILLA L BUCHHOLZ RA VANALLER G HAMEL LT BACON E SINGH B LESHER GY HLASTA D PAGANI ED
Citation: Pj. Silver et al., CYCLIC-GMP POTENTIATION BY WIN-58237, A NOVEL CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1143-1149

Authors: MANGIAPANE ML RAUCH AL CUSHING DJ BUCHHOLZ RA
Citation: Ml. Mangiapane et al., VASOPRESSOR ACTIVITY OF ANG I-CONVERTASE (HUMAN HEART CHYMASE) AND A SYNTHETIC SUBSTRATE (PRO11, D-ALA12 ANG-I), Hypertension, 22(3), 1993, pp. 443-443

Authors: DUNDORE RL CLAS DM WHEELER LT HABEEB PG BODE DC BUCHHOLZ RA SILVER PJ PAGANI ED
Citation: Rl. Dundore et al., ZAPRINAST INCREASES CYCLIC-GMP LEVELS IN PLASMA AND IN AORTIC TISSUE OF RATS, European journal of pharmacology, 249(3), 1993, pp. 293-297
Risultati: 1-16 |